In an effort to stop the spread, the FDA is signing
off on two new at-home COVID-19 tests.
The Roche and Siemens
at-home tests are the first to gain authorization through the FDA's new
accelerated review program.
That program is expected to
help bring tens of millions of new tests per month to the U.S.
It comes after the
Department of Health and Human Services announced a $70 million investment to
produce more at-home tests.